G

Graphite Bio

122 employees

Graphite Bio is a next-generation gene editing company that is driven to apply our breakthrough technology.

Basic info

Industry

biotechnology research

Sectors

CRISPR
Biotechnology
biotechnology
clinical development
gene therapy
gene editing
research
sickle cell disease

Date founded

2020

Funding rounds raised

Total raised

$151M

from 9 investors over 9 rounds

G

Graphite Bio raised $151M on March 15, 2021

Investors: Samsara BioCapital, OrbiMed Advisors, RA Capital Management, L.P., Surveyor Capital, Logos Global Management, LP, Versant Ventures and Perceptive Advisors

G

Graphite Bio raised $45M on September 16, 2020

Investors: Versant Ventures and Samsara BioCapital

FAQ